BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8438351)

  • 1. CD46 (MCP) confers protection from lysis by xenogeneic antibodies.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transplant Proc; 1993 Feb; 25(1 Pt 1):396-7. PubMed ID: 8438351
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular basis of CD46 polymorphic expression and demonstration of a protective role against lysis by xenosera.
    Loveland B; Russell S; Purcell D; Johnstone R; Thorley B; Sparrow R; McKenzie I
    Transplant Proc; 1992 Apr; 24(2):685-6. PubMed ID: 1632880
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytoprotective effect of CD59 antigen on xenotransplantation immunity.
    Akami T; Sawada R; Minato N; Naruto M; Yamada A; Imanishi J; Mitsuo M; Nakai I; Okamoto M; Nakajima H
    Transplant Proc; 1992 Apr; 24(2):485-7. PubMed ID: 1373542
    [No Abstract]   [Full Text] [Related]  

  • 4. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
    Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
    Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part I: in vitro assays using porcine aortic endothelial cells.
    Nagahama M; Shiraishi M; Oshiro T; Taira K; Sugawa H; Nozato E; Nomura H; Nagamine M; Muto Y
    Transpl Int; 2002 May; 15(5):205-11. PubMed ID: 12012040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-mediated gene transfer of triple human complement regulating proteins (DAF, MCP and CD59) in the xenogeneic porcine-to-human transplantation model. Part II: xenogeneic perfusion of the porcine liver in vivo.
    Shiraishi M; Oshiro T; Nozato E; Nagahama M; Taira K; Nomura H; Sugawa H; Muto Y
    Transpl Int; 2002 May; 15(5):212-9. PubMed ID: 12012041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of xenogeneic cell-mediated lympholysis between human and pig cells.
    Yamada K; DerSimonian H; Sachs DH
    Transplant Proc; 1996 Apr; 28(2):757. PubMed ID: 8623383
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non-immunosuppressed baboons.
    Loveland BE; Milland J; Kyriakou P; Thorley BR; Christiansen D; Lanteri MB; Regensburg M; Duffield M; French AJ; Williams L; Baker L; Brandon MR; Xing PX; Kahn D; McKenzie IF
    Xenotransplantation; 2004 Mar; 11(2):171-83. PubMed ID: 14962279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different membrane cofactor protein (CD46) isoforms protect transfected cells against antibody and complement mediated lysis.
    Loveland BE; Johnstone RW; Russell SM; Thorley BR; McKenzie IF
    Transpl Immunol; 1993; 1(2):101-8. PubMed ID: 8081768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis.
    Kojima A; Iwata K; Seya T; Matsumoto M; Ariga H; Atkinson JP; Nagasawa S
    J Immunol; 1993 Aug; 151(3):1519-27. PubMed ID: 8335944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transfected complement regulatory proteins, MCP, DAF, and MCP/DAE hybrid, on complement-mediated swine endothelial cell lysis.
    Miyagawa S; Shirakura R; Iwata K; Nakata S; Matsumiya G; Izutani H; Matsuda H; Terado A; Matsumoto M; Nagasawa S
    Transplantation; 1994 Oct; 58(7):834-40. PubMed ID: 7524206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transfectant molecules, MCP, DAF, and MCP/DAF hybrid on xenogeneic vascular endothelium.
    Miyagawa S; Shirakura R; Izutani H; Matsumiya G; Nakata S; Matsuda H; Iwata K; Nagasawa S; Terado A; Matsumoto M
    Transplant Proc; 1994 Jun; 26(3):1253-4. PubMed ID: 7518122
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of human CD59 antigen in discordant xenotransplantation between humans and nonprimates.
    Akami T; Arakawa K; Okamoto M; Sawada R; Naruto M; Oka T
    Transplant Proc; 1993 Feb; 25(1 Pt 1):394-5. PubMed ID: 7679814
    [No Abstract]   [Full Text] [Related]  

  • 14. Functional expression of human CD59 in transgenic mice.
    Somerville CA; Kyriazis AG; McKenzie A; Allison J; Pearse MJ; D'Apice AJ
    Transplantation; 1994 Dec; 58(12):1430-5. PubMed ID: 7528953
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro and in vivo studies to prevent hyperacute rejection.
    Miyagawa S; Mikata M; Matsuda H; Ikawa M; Okabe M; Nagasawa S; Matsumoto M; Seya T; Shirakura R
    Transplant Proc; 1996 Apr; 28(2):1031-3. PubMed ID: 8623217
    [No Abstract]   [Full Text] [Related]  

  • 16. Presence of a complement-dependent "cytotoxic factor" in dog serum: relevance to experimental discordant xenotransplantation.
    Baker J; Martin M; Ye Y; Oleinick S; Zuhdi N; Cooper DK
    Transplant Proc; 1992 Apr; 24(2):490-1. PubMed ID: 1566399
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement.
    White DJ; Oglesby T; Liszewski MK; Tedja I; Hourcade D; Wang MW; Wright L; Wallwork J; Atkinson JP
    Transplant Proc; 1992 Apr; 24(2):474-6. PubMed ID: 1373541
    [No Abstract]   [Full Text] [Related]  

  • 18. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
    Capey S; van den Berg CW
    Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59.
    Miyagawa S; Shirakura R; Mikata S; Tanemura M; Fukushima N; Matsuda H; Terado A; Hatanaka M; Matsumoto M; Seya T
    Transplant Proc; 1996 Apr; 28(2):597-8. PubMed ID: 8623293
    [No Abstract]   [Full Text] [Related]  

  • 20. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
    Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
    FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.